IXICO plc (AIM: IXI) – strong interim results from the brain health company
IXICO plc, the brain health company, today announced its interim results for the six months ended 31 March 2015, showing strong progress in the period.
IXICO brings innovative technologies to those involved in researching and treating serious diseases, enabling them to help patients quicker. Their business has three core sections. The first being in clinical trials where they offer digital tools to support decision making and analysis. This section of the business brings in the highest revenue at present.
The second area of the business is in experimental medicine where IXICO work with pharmaceutical companies to research new tools…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on IXICO PLC
13/03/2024 · Company Insights
This medical imaging advanced analytics company delivering insights in neuroscience, had been growing fast over recent years…
19/07/2023 · Company Insights
News covered here includes results and updates from several companies trading at very modest valuations and…
More Company Insights
Results include commendable returns from an AIM elder
Doing well in the biggest market of all
Another upgrade and strong results for our bargain stocks
More on IXICO PLC
More Company Insights